首页 | 本学科首页   官方微博 | 高级检索  
     

糖尿病视网膜病变患者玻璃体中肝细胞生长因子的含量检测
引用本文:王丽丽,黄玲,朱赛林. 糖尿病视网膜病变患者玻璃体中肝细胞生长因子的含量检测[J]. 中华眼底病杂志, 2002, 18(2): 131-133
作者姓名:王丽丽  黄玲  朱赛林
作者单位:710004,西安市第四医院眼科
摘    要:目的 定量研究肝细胞生长因子(hepatocyte growth factor, HGF)在糖尿病视网膜病变(diabetic retinopathy, DR)患者玻璃体中的水平,探讨HGF在增生性糖尿病视网膜病变 (proliferative diabetic retinopathy, PDR)等新生血管形成病理过程中的作用。 方法 采用双夹心酶联免疫吸附测定法检测对照组10只眼玻璃体以及单纯型DR组7只眼、PDR组33只眼和其它与新生血管生成有关的视网膜疾病组8只眼玻璃体切割手术中所取玻璃体内HGF的含量。PDR组中无虹膜新生血管者24只眼,伴虹膜新生血管者9只眼。 结果 玻璃体中HGF的含量对照组为(3.34±1.9)μg/L;单纯型DR组为(4.8±2.5)μg/L;PDR组中不伴虹膜新生血管生成者为(13.0±5.2)μg/L;PDR伴有虹膜新生血管生成者为(18.6±7.2)μg/L,其它与新生血管生成有关的视网膜疾病组为(12.1±8.9)μg/L。PDR组和其它与新生血管生成有关的视网膜疾病组玻璃体中HGF的含量比对照组显著升高(t=6.49, 5.70, 3.01, P<0.01);PDR组中伴有虹膜新生血管生成者较PDR不伴虹膜新生血管生成者以及单纯型DR组玻璃体中HGF的含量均高,其差异有显著性意义(t=2.47, P<0.05或t=4.84, P<0.01)。 结论 在PDR和与新生血管生成有关的视网膜疾病患眼玻璃体内HGF的含量升高,提示HGF可能在视网膜新生血管生成的病理过程中起一定作用。 (中华眼底病杂志, 2002, 18: 131-13)

关 键 词:玻璃体 糖尿病视网膜病变 肝细胞生长因子 酶联免疫吸附测定 血管形成 DR
收稿时间:2001-10-22
修稿时间:2001-10-22

A comparative study of hepatocyte growth factor levels in the vitreous of patients with diabetic retinopathy
WANG Li-li,HUANG Ling,ZHU Sai-lin. A comparative study of hepatocyte growth factor levels in the vitreous of patients with diabetic retinopathy[J]. Chinese Journal of Ocular Fundus Diseases, 2002, 18(2): 131-133
Authors:WANG Li-li  HUANG Ling  ZHU Sai-lin
Affiliation:Department of Ophthalmology, Xian Forth Hospital, Xi&#146;an 710004,China
Abstract:Objective To determine the concentration of hepatocyte growth factor (HGF) in vitreous of diabetic retinopathy (DR) and investigate the result and influence of HGF in neovascularization in proliferative diabetic retinopathy (PDR). Methods The high sensitive sandwich enzyme-linked immunosorbent assay (ELISA) was used to measure the level of HGF in vitreous of normal group for 10 eyes, simple DR group for 7 eyes, PDR without iridal neovascularization group for 24 eyes, PDR with neovascularization of iris group in 9 eyes, other retinopathy group associated with neovascularization for 8 eyes. Results The mean value of HGF level in vitreous of the former groups was: (3.3 ±1.9) μg/L in normal group; (4.8±2.5) μg/L in simple DR group; (13.0 ±5.2) μg/L in PDR without iridal neovascularization group; (18.6±7.2) μg/L in PDR with neovascularization of iris group;(12.1±8.9) μg/L in other retinopathy associated with neovascularization group. Stastistics showed that HGF level in PDR group and other retinal diseases associated with neovascularization were significantly higher than that in normal group (P<0.01), PDR with neovascularization of iris group showed a higher mean vitreous HGF concentration than those in PDR without iridal neovascularization and simple DR group (P<0.05 or P<0.01). Conclusion Our results indicate that vitreous HGF may play an important role in retinal neovascularization in PDR and other retinal diseases. (Chin J Ocul Fundus Dis, 2002, 18: 131-133)
Keywords:Diabetic retinopathy/enzymology  Hepatocyte growth factor/analysis  Enzyme linked immunosorbent assay
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中华眼底病杂志》浏览原始摘要信息
点击此处可从《中华眼底病杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号